Improving efficacy and reducing toxicity of anti-PD-L1 treatment: T-cells as delivery vehicles for anti-PD-L1 blocking nanobodies

被引：0
|
作者：
Petit, P-F. [1 ]
Zhu, J. [1 ]
van den Eynde, B. J. [1 ]
机构：
[1] Ludwig Inst Canc Res, De Duve Inst, Brussels, Belgium
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.10.511
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
25P
引用
收藏
页码：S1425 / S1425
页数：1
相关论文
共 50 条
  • [11] Noninflammatory adjuvant improving dendritic cell priming and anti-PD-L1 efficacy
    Seya, Tsukasa
    Takeda, Yohei
    Matsumoto, Misako
    CANCER SCIENCE, 2018, 109 : 551 - 551
  • [12] Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies
    Naidoo, J.
    Page, D. B.
    Li, B. T.
    Connell, L. C.
    Schindler, K.
    Lacouture, M. E.
    Postow, M. A.
    Wolchok, J. D.
    ANNALS OF ONCOLOGY, 2015, 26 (12) : 2375 - 2391
  • [13] The Evolving Landscape of Biomarkers for Anti-PD-1 or Anti-PD-L1 Therapy
    Tunger, Antje
    Sommer, Ulrich
    Wehner, Rebekka
    Kubasch, Anne Sophie
    Grimm, Marc-Oliver
    Bachmann, Michael Philipp
    Platzbecker, Uwe
    Bornhaeuser, Martin
    Baretton, Gustavo
    Schmitz, Marc
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (10)
  • [14] Anti-PD-L1 Treatment Induced Central Diabetes Insipidus
    Zhao, Chen
    Tella, Sri Harsha
    Del Rivero, Jaydira
    Kommalapati, Anuhya
    Ebenuwa, Ifechukwude
    Gulley, James
    Strauss, Julius
    Brownell, Isaac
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (02): : 365 - 369
  • [15] Effect of NK cell treatment on PD-L1 expression and anti-PD-L1 response
    Copik, Alicja
    Oyer, Jeremiah
    Gitto, Sarah
    Altomare, Deborah
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [16] In vivo efficacy of intraperitoneal anti-PD-L1 therapy in ovarian cancer
    Grabosch, Shannon
    Mony, Jyothi T.
    Zhang, Lixin
    Ma, Tianzhou
    Tirodkar, Tejas
    Brozick, Joan
    Tseng, George
    Elishaev, Esther
    Edwards, Robert P.
    Huang, Xin
    Vlad, Anda M.
    CANCER RESEARCH, 2015, 75
  • [17] Hair RepigmentationWith Anti-PD-1 and Anti-PD-L1 Immunotherapy: A Novel Hypothesis
    Sebaratnam, Deshan Frank
    Rodriguez Bandera, Ana Isabel
    Lowe, Patricia Margaret
    JAMA DERMATOLOGY, 2018, 154 (01) : 112 - 113
  • [18] Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy
    Swaika, Abhisek
    Hammond, William A.
    Joseph, Richard W.
    MOLECULAR IMMUNOLOGY, 2015, 67 (02) : 4 - 17
  • [19] Evaluation of niraparib in combination with anti-PD1/anti-PD-L1 in preclinical models
    Wang, Sarah
    Sun, Kaiming
    Xiao, Yonghong
    Feng, Bin
    Mikule, Keith
    Ramaswamy, Sridhar
    Hanke, Jeffrey
    Wang, Jing
    CANCER RESEARCH, 2018, 78 (13)
  • [20] New insights into the anti-PD-L1 and anti-PD-1 reagents in cancer therapy
    Chen, Cheng
    Huang, Jian-An
    EUROPEAN JOURNAL OF INFLAMMATION, 2016, 14 (01) : 61 - 65
12345